TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biotrans i Nord AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
10,424
|
14,969
|
15,324 |
Financial expenses |
291
|
153
|
93 |
Earnings before taxes |
-2,032
|
-538
|
2 |
EBITDA |
-127
|
1,114
|
1,392 |
Total assets |
18,335
|
13,409
|
11,243 |
Current assets |
4,514
|
2,249
|
2,196 |
Current liabilities |
5,086
|
4,626
|
3,814 |
Equity capital |
650
|
737
|
1,155 |
- share capital |
500
![]() |
500
![]() |
500 |
Employees (average) |
8
![]() |
8
|
10 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
3.5%
|
5.5%
|
10.3% |
Turnover per employee |
1,303
|
1,871
|
1,532 |
Profit as a percentage of turnover |
-19.5%
|
-3.6%
|
0.0% |
Return on assets (ROA) |
-9.5%
|
-2.9%
|
0.8% |
Current ratio |
88.8%
|
48.6%
|
57.6% |
Return on equity (ROE) |
-312.6%
|
-73.0%
|
0.2% |
Change turnover |
-4,545
|
-355
|
2,718 |
Change turnover % |
-30%
|
-2%
|
22% |
Chg. No. of employees |
0
|
-2
|
0 |
Chg. No. of employees % |
0%
|
-20%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.